[PDF] Position statement : biosimilar insulins

Source:
Diabetes UK
Publisher:
Diabetes UK
Publication date:
06 September 2019

Abstract

Biosimilar insulin is a biological copy of an original insulin and there is increasing interest in developing and using them. 

Biosimilar insulins are cheaper than original products so they present the NHS with opportunities around availability and cost of care. However, there is lack of awareness among healthcare professionals and people with diabetes about their use.

Diabetes UK has put together this position statement to raise awareness, and to support decision making in prescribing.